ChemoCentryx Inc reports results for the quarter ended in December - Earnings Summary

Churchill Capital XI

02/03/2022 04:02

* ChemoCentryx Inc  CCXI.OQ  reported a quarterly adjusted
loss
of 58 cents​​ per share for the quarter ended in December. The
mean expectation of eight analysts for the quarter was for a
loss of 58 cents per share.
    * Revenue fell 46.9% to $2.32 million from a year ago; 
analysts
expected $4.22 million. 
    * ChemoCentryx Inc's reported EPS for the quarter was a loss
of 58
cents​.
    * The mean earnings estimate of analysts had fallen by
about 75.6%
in the last three months.​ 
    * In the last 30 days three analysts negatively revised
earnings
estimates 
    * ChemoCentryx Inc shares had fallen by 16.7% this quarter.
    * The company reported a quarterly loss of $40.53 million.
    * Wall Street's median 12-month price target for
ChemoCentryx Inc
is $64.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 2 at 04:02 a.m.  ​All
figures in US dollars unless otherwise stated